Search results for "Cycloastragenol"
showing 2 items of 2 documents
Cycloastragenol as an Exogenous Enhancer of Chondrogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells. A Morphological Study
2020
Stem cell therapy and tissue engineering represent a promising approach for cartilage regeneration. However, they present limits in terms of mechanical properties and premature de-differentiation of engineered cartilage. Cycloastragenol (CAG), a triterpenoid saponin compound and a hydrolysis product of the main ingredient in Astragalus membranaceous, has been explored for cartilage regeneration. The aim of this study was to investigate CAG&rsquo
Two New Acylated Tridesmosidic Saponins from Astragalus armatus
2010
Two new tridesmosidic glycosides of (3β,6α,16β,20R,24S)-20,24-epoxycycloartane-3,6,16,25-tetrol (=cycloastragenol), armatosides I and II (1 and 2, resp.), were isolated from the roots of Astragalus armatus (Fabaceae) as well as the known bidesmosidic glycosides of cycloastragenol, trigonoside II (3) and trojanoside H (4). Their structures were elucidated as (3β,6α,16β,20R,24S)-3-O-(2,3-di-O-acetyl-β-D-xylopyranosyl)-20,24-epoxy-25-O-β-D-glucopyranosyl-6-O-β-D-xylopyranosylcycloartane-3,6,16,25-tetrol (1), and (3β,6α,16β,20R,24S)-3-O-(2-O-acetyl-β-D-xylopyranosyl)-20,24-epoxy-25-O-β-D-glucopyranosyl-6-O-β-D-xylopyranosylcycloartane-3,6,16,25-tetrol (2). These structures were established by e…